• Submitted by: admin
• Asia
• International
• Health and Medicine
• Science and Technology
• 07 / 26 / 2007

The vaccine EGF-P64K, against cancer, is not prophylactic, but therapeutic, to fight the growing carcinogenic cells, doctors Gisela Gonzalez, the project's manager and Carmen Barroso, oncologist of the CIM clinic research board of directors, explained after starting the testing stage.

"Relations between Cuba and Malaysia began many years ago, and we will maintain our support of this project against cancer," Malaysian Health Vice-minister Abdul Latiff Ahmad said.

Based on the Epidermal Growth Factor, the Cuban product seeks to improve the life quality of patients with advanced lung cancer.

Malaysian specialists will be testing the Cuban vaccine on 230 voluntary patients from 14 hospitals of Malaysia, over two and a half years.

Source: Prensa Latina